This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/10/2021
Welcome to today's report comment. With me in the studio today is Anna Ahlberg, she is CFO at Certical Science. Welcome Anna. Thank you. And congratulations on a strong quarter. Thank you so much. The net turnover rose to about 95 million, an increase of 282%. What do you think has been the key to this progress?
We are very happy and satisfied with both the sales and the start of the collaboration in the new group. We made a large acquisition this summer of Symbionics, which does a lot of the same things as us, but has a much broader product portfolio and was about three and a half times as big as us. And they are included in the figures for part of the quarter, so it's a mixed quarter. for about a month. But even if we look at comparable units and compare this quarter with the same quarter last year, as if we also had been the same group, we increase by over 30%. And we are very pleased with that. And that is the increase in both of our two business areas.
We are going to talk more about the integration of Symbionics, but your internal motto is to keep the engine running. What has this meant to you?
You're reading a preview of the SUS.ST Q3 2021 earnings call.
Free account.
